Ads
related to: thermo
Search results
Thermo Fisher Scientific Inc.'s (NYSE:TMO) Stock Is Going Strong: Is the Market Following...
Simply Wall St. via Yahoo Finance· 3 days agoThermo Fisher Scientific (NYSE:TMO) has had a great run on the share market with its stock up by a...
Thermo Fisher (TMO) Up 2.3% Since Last Earnings Report: Can It Continue?
Zacks via Yahoo Finance· 8 hours agoIt has been about a month since the last earnings report for Thermo Fisher Scientific (TMO). Shares...
Zacks Research Equities Analysts Boost Earnings Estimates for Thermo Fisher Scientific Inc....
ETF DAILY NEWS· 4 days agoThermo Fisher Scientific Inc. (NYSE:TMO – Free Report) – Equities researchers at Zacks Research boosted their Q4 2024 earnings estimates ...
If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,200 Today - Thermo Fisher ...
Benzinga· 2 days agoThermo Fisher Scientific TMO has outperformed the market over the past 5 years by 3.77% on an annualized basis producing an average annual ...
Thermo Fisher Scientific Inc. (TMO) Stock: A Closer Look at the Analyst Ratings – News Heater
NewsHeater· 18 hours agoThermo Fisher Scientific Inc. (NYSE: TMO) has a price-to-earnings ratio of 37.53x that is above its average ratio. Thermo< ...
Boston Partners Cuts Stock Position in Thermo Fisher Scientific Inc. (NYSE:TMO)
ETF DAILY NEWS· 6 days agoBoston Partners reduced its position in Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by 52.0% during the 4th quarter, according ...
Thermo Fisher sets quarterly dividend at $0.39 per share By Investing.com
Investing.com· 2 days agoThermo Fisher Scientific Inc. (NYSE: NYSE:TMO), a prominent player in serving the scientific...
Thermo Fisher Scientific Inc. (TMO) gets rating Resumed from Citigroup – Knox Daily
Knox Daily· 5 days agoThermo Fisher Scientific Inc.’s recent filing unveils that its Executive Vice President & COO Lagarde Michel unloaded Company’s shares ...
The gluconeogenesis enzyme PCK2 has a non-enzymatic role in proteostasis in endothelial cells -...
Nature· 2 days agoThis study reports a unexpected role in endothelial cells (ECs) for PCK2 in proteostasis, independent of its gluconeogenic activity. Perturbation of this role likely contributed to the angiogenic defects observed in ECs with reduced PCK2 levels.
In Brief This Week: ERS Genomics, Lunit, Agilent, Thermo Fisher, Congenica, Oxford BioDynamics, More
GenomeWeb News· 10 hours agoERS Genomics this week said it has signed a nonexclusive licensing agreement for CRISPR-Cas9 patents with Italian contract research organization IRBM. Lunit will integrate Volpara's breast health ...
